University Hospital Tuebingen: Diabetes Mellitus, Type 2 trials

The registry lists 13 Diabetes Mellitus, Type 2 studies with University Hospital Tuebingen as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 4No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2DRecruitingNCT05856877Not applicable
• Enhancing Brain Health by TDCS in Persons with Overweight and ObesityActive, not recruitingNCT05228067Not applicable
• MR-based Characterization of Bone Marrow in Its Relevance to Skeletal Disease in Patients With DiabetesActive, not recruitingNCT04950283
• Effects of Insulin Glargine and Lixisenatide on the BrainTerminatedNCT03881995Phase 4
• Raclopride-PET/MRTCompletedNCT03637075Not applicable
• Effect of High Caloric Diet on Brain Insulin Sensitivity and InflammationCompletedNCT03590561Not applicable
• Empagliflozin Effect on Glucose ToxicityWithdrawnNCT03437330Phase 4
• Dapagliflozin Effect on Erythropoiesis and Physical FitnessWithdrawnNCT03423355Phase 4
• Nutritional Prevention of Diabetes Mellitus Type 2CompletedNCT03231839Not applicable
• Dapagliflozin + Saxagliptin in a Basal-bolus Insulin TreatmentTerminatedNCT02965443Phase 4
• Study of Carrageenan's Effect on Insulin Resistance in HumansCompletedNCT02629705Not applicable
• Individualized Lifestyle Intervention in Subjects With PrediabetesCompletedNCT01947595Not applicable
• Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin GlargineTerminatedNCT00656422Phase 3